The Pharmaceutical Solid Dosage Contract Manufacturing segmentation by application delineates the market into tablets, capsules, granules, and powders. Tablets dominate the landscape, representing roughly 55 % of contract volumes, driven by their manufacturing scalability, patient compliance, and extensive therapeutic coverage. Capsules account for about 30 % and are favored for moisture‑sensitive APIs and ease of swallowing, supporting niche markets such as nutraceuticals and specialty drugs. Granules, contributing 10 %, serve as intermediate forms for sachet‑based reconstitution or as precursors for further processing, reflecting demand in pediatric and emergency‑care segments. Powders, at 5 %, are primarily employed for inhalation blends and topical formulations, indicating a modest but strategic role in diversified dosage pipelines. Each application segment adds distinct value‑chain requirements—equipment, process validation, and regulatory oversight—that collectively shape the overall market size and growth trajectory.